[go: up one dir, main page]

IL147534A0 - The il-il1 gene and polypeptide products - Google Patents

The il-il1 gene and polypeptide products

Info

Publication number
IL147534A0
IL147534A0 IL14753400A IL14753400A IL147534A0 IL 147534 A0 IL147534 A0 IL 147534A0 IL 14753400 A IL14753400 A IL 14753400A IL 14753400 A IL14753400 A IL 14753400A IL 147534 A0 IL147534 A0 IL 147534A0
Authority
IL
Israel
Prior art keywords
gene
polypeptide products
polypeptide
products
Prior art date
Application number
IL14753400A
Other languages
English (en)
Original Assignee
Interleukin Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interleukin Genetics Inc filed Critical Interleukin Genetics Inc
Publication of IL147534A0 publication Critical patent/IL147534A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
IL14753400A 1999-07-16 2000-07-17 The il-il1 gene and polypeptide products IL147534A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14429899P 1999-07-16 1999-07-16
PCT/US2000/019508 WO2001005974A2 (fr) 1999-07-16 2000-07-17 Gène il-1l1 et produits polypeptidiques

Publications (1)

Publication Number Publication Date
IL147534A0 true IL147534A0 (en) 2002-08-14

Family

ID=22507973

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14753400A IL147534A0 (en) 1999-07-16 2000-07-17 The il-il1 gene and polypeptide products

Country Status (6)

Country Link
EP (1) EP1200593A2 (fr)
JP (1) JP2003523943A (fr)
AU (1) AU6219400A (fr)
CA (1) CA2378954A1 (fr)
IL (1) IL147534A0 (fr)
WO (1) WO2001005974A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999035268A1 (fr) 1998-01-09 1999-07-15 Immunex Corporation Adn codant il-1 delta et polypeptides il-1 delta
US20030100031A1 (en) * 2001-06-11 2003-05-29 Steven Dower Integrative assays for monitoring molecular assembly events
EP1585482A4 (fr) * 2002-09-25 2009-09-09 Genentech Inc Nouvelles compositions et methodes de traitement du psoriasis
US20100031378A1 (en) 2008-08-04 2010-02-04 Edwards Joel A Novel gene disruptions, compositions and methods relating thereto
US20070178520A1 (en) * 2004-02-27 2007-08-02 Barbara Wolff-Winiski Screening assay for modulators of interaction between interleukin-12 and/or -23 with their receptors
CA2662549C (fr) * 2006-09-08 2014-10-28 Amgen Inc. Variants de la famille il-1
EP3554343A1 (fr) * 2016-12-14 2019-10-23 Progenity, Inc. Traitement d'une maladie du tractus gastro-intestinal avec un inhibiteur d'il-1
CN107362351B (zh) * 2017-09-04 2020-11-10 上海市儿童医院 Il-36r的拮抗剂在制备镇痛药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0977779A1 (fr) * 1997-04-21 2000-02-09 Schering Corporation Cytokines de mammifere; reactifs et procedes connexes
WO1999035268A1 (fr) * 1998-01-09 1999-07-15 Immunex Corporation Adn codant il-1 delta et polypeptides il-1 delta
AU769262B2 (en) * 1998-04-03 2004-01-22 Arca Biopharma, Inc. A interleukin-1 receptor antagonist and uses thereof
AU5772299A (en) * 1998-08-07 2000-02-28 Millennium Pharmaceuticals, Inc. Novel molecules of the tango-93-related protein family and uses thereof
WO2000020595A1 (fr) * 1998-10-08 2000-04-13 Zymogenetics, Inc. Homologues de l'interleukine-1
JP5456222B2 (ja) * 1998-12-23 2014-03-26 ジェネンテック， インコーポレイテッド Ｉｌ−１関連ポリペプチド

Also Published As

Publication number Publication date
WO2001005974A3 (fr) 2001-05-10
WO2001005974A9 (fr) 2001-06-28
EP1200593A2 (fr) 2002-05-02
JP2003523943A (ja) 2003-08-12
WO2001005974A2 (fr) 2001-01-25
CA2378954A1 (fr) 2001-01-25
AU6219400A (en) 2001-02-05

Similar Documents

Publication Publication Date Title
IL147145A0 (en) ANTI-αvβ3 RECOMBINANT HUMAN ANTIBODIES AND NUCLEIC ACIDS ENCODING THE SAME
AP2001002227A0 (en) Colapsible crate and associated connecting means
HUP0001603A3 (en) Cycloalkylalkanecarboxamides and the production and use thereof
IL128193A0 (en) Rhamnosyl-transferase gene and uses thereof
AU2841801A (en) Triazolotriazinones and the use thereof
GB9928490D0 (en) Products and processes therefor
IL131707A0 (en) Acetylcholinesterase-derived peptides and uses thereof
EP1186615A4 (fr) Proteine et adn de cette proteine
IL120554A (en) Kombucha products and processes for the preparation thereof
IL147534A0 (en) The il-il1 gene and polypeptide products
AU1891301A (en) Novel polypeptide and dna thereof
AU3511100A (en) Novel nucleic acids and polypeptides
HUP0201660A2 (en) Novel polypeptide and dna thereof
IL149506A0 (en) Human heparanase-related polypeptide and nucleic acid
HUP0201022A2 (en) Outer surface proteins, their genes, and their use
EP1099755A4 (fr) Nouveau gene et transformant portant ce gene
GB9917165D0 (en) Polypeptides polynuclcotides and uses thereof
PL354184A1 (en) The prv-1 gene and use thereof
IL145233A0 (en) Recombinant plant proteins and methods utilizing the same
HUP0104954A3 (en) Prv-1 gene and the use thereof
EP1189920A4 (fr) Famille de genes camello et l'utilisation desdits genes
EP1063290A4 (fr) Nouvelle dicarbonylreductase et gene la codant
AU5476600A (en) Gene specific arrays and the use thereof
AU3364401A (en) Modified nucleic acids and their use
GB0208293D0 (en) Nrage nucleic acids and polypeptides and uses thereof